Orthofix International | OFIX - Equity Capital And Reserves


Orthofix International reported $442.49M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AngioDynamics USD 185.87M 898K Feb/2025
AtriCure USD 476.51M 12.02M Sep/2025
Dexcom USD 2.73B 153M Sep/2025
EDAP TMS EUR 27.82M 13.07M Jun/2025
Globus Medical USD 4.4B 103.14M Sep/2025
Hologic USD 5.25B 197.2M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.38B 78.8M Sep/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
J&J USD 78.47B 0 Sep/2025
Medtronic USD 47.89B 131M Jun/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 442.49M 15.86M Sep/2025
Plus Therapeutics USD -1.35M 3.97M Dec/2023
Smith & Nephew USD 5.54B 331M Dec/2025
STAAR Surgical USD 353.78M 17.21M Sep/2025
Stryker USD 21.78B 594M Sep/2025
Surmodics USD 118.9M 753K Sep/2024
Tandem Diabetes Care USD 132.96M 318K Sep/2025
Teleflex USD 3.82B 421M Sep/2025
Veracyte USD 1.26B 36.61M Sep/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025